## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi
Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study
✍ Scribed by Jun Soo Kwon; Joon Hwan Jang; Do-Hyung Kang; So Young Yoo; Yong Ku Kim; Seong-Jin Cho; the APLUS study group
- Book ID
- 108962373
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 248 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1323-1316
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac
## Abstract ## Objective To determine the effect of intramuscular (IM) olanzapine in severely agitated patients. ## Methods This was an open‐label multicenter 1‐week observational study of IM olanzapine treatment in severely agitated inpatients and psychiatric emergency services with bipolar man